Adult human bone marrow (ABM) is an important source of hematopoietic stem cells for transplantation in the treatment of malignant and non-malignant diseases. However, unlike the recent progress which has been achieved with umbilical cord blood, methods to expand ABM stem cells for therapeutic applications have been disappointing. In this study, we describe a novel culture method utilizing human brain endothelial cells (HUBEC) which supports the quantitative expansion of the most primitive measurable cell within the adult bone marrow compartment, the NOD/SCID repopulating cell (SRC). Co-culture of human ABM CD34 + cells with brain endothelial cells for 7 days supported a 5.4 fold increase in CD34 + cells, induced >95% of the CD34 + CD38subset to enter cell division, and produced progeny which engrafted NOD/SCID mice at significantly higher rates than fresh ABM CD34 + cells. Using a limiting dilution analysis, we found the frequency of SRC within fresh ABM CD34 + cells to be 1 in 9.9 x 10 5 cells. Following HUBEC culture, the estimated frequency of SRC increased to 1 in 2.4 x 10 5 cells. All mice transplanted with HUBEC-cultured cells showed B lymphoid and myeloid differentiation, indicating that a primitive hematopoietic cell was preserved during culture. Non-contact HUBEC cultures also maintained SRC at a level comparable to contact HUBEC cultures, suggesting that cellto-cell contact was not required. These data demonstrate that human brain endothelial cells possess a unique hematopoietic activity which increases the repopulating capacity of adult human bone marrow.
Introduction
The development of ex vivo culture methods that promote the expansion of adult human bone marrow (ABM) stem cells would have direct application in clinical gene therapy and stem cell transplantation. However, results obtained from stroma-based 1 and stroma-free ex vivo culture systems [2] [3] [4] [5] have been disappointing, due to insufficient activation of primitive CD34 + CD38cells, cell differentiation, and a loss of repopulating capacity following short term culture. 6 Moreover, increased CD34 + cell numbers, colony-forming cells (CFC), and long-term culture initiating cells (LTC-IC) are not quantitative indicators of in vivo repopulating potential. 7-10 Therefore, the importance of evaluating ex vivo cultured cells in an in vivo repopulation model has been emphasized. 8 The NOD/SCID model system has been used to measure the long-term reconstitution potential of ex vivo expanded human lymphohematopoietic stem cells. 7-10 SCID-repopulating cells (SRC) are enriched in human cord blood (CB) as compared to adult ABM and mobilized peripheral blood 11, 12 and are most highly concentrated within the CD34 + CD38population. 8 SRC are considered to be biologically more primitive than assayable LTC-IC and CFC progenitors 1, 9, 10, 13 which are found in both the CD34 + CD38 + and CD34 + CD38pools. 8 As further evidence, gene transduction studies have shown that LTC-IC and CFC are readily transduced but contribute little to NOD/SCID engraftment. 2, 7 For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From When human hematopoietic stem cells (HSC) are co-cultured in contact with bone marrow stroma or conditioned medium from stromal cultures, a percentage of LTC-IC and CFC can be expanded in vitro over several weeks. [14] [15] [16] [17] Similarly, bone marrow, umbilical vein, and yolk sac-derived endothelial cell cultures elaborate growth factors which regulate hematopoiesis [18] [19] [20] and support the proliferation of myeloid, erythroid, and megakaryocytic progenitors. 19, 20 We have previously demonstrated that a porcine brain microvascular endothelial cell line (PMVEC) plus cytokines was capable of supporting a robust expansion of human CD34 + CD38progenitors 21,22 while maintaining cells capable of repopulating SCID-Hu bone 23 as well as cells capable of rescuing lethally irradiated baboons. 24 In these studies, we did not quantify the frequency of repopulating cells in the transplanted grafts.
Recent studies utilizing rigorous limiting dilution analyses have demonstrated that both stroma-containing and stroma-free culture conditions can support the quantitative expansion of SRC within human CB. [25] [26] [27] [28] However, the ex vivo expansion of human ABM stem cells under similarly stringent conditions has not been demonstrated. In fact, a recent limiting dilution analysis demonstrated a 6-fold decline in SRC within human ABM during short-term culture with ABM stroma. 1 In this study, using quantitative limiting dilution analysis, we demonstrate that the number of engraftable SRC within human ABM increases following co-culture with primary human brain endothelial cells (HUBEC). The HUBEC ex vivo culture system has potential application in the expansion of ABM stem cells for clinical transplantation and
For personal use only. on April 15, 2017 . by guest www.bloodjournal.org From will also be a new resource for the identification of molecules which affect stem cell self renewal.
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Materials and Methods

Isolation of primary human brain endothelial cells (HUBEC)
Vessel segments (< 10 cm) from the central nervous system and outside the CNS (renal artery) were collected from cadavers within 12 hours post-mortem under an approved tissue procurement protocol. Vessel segments were placed in complete endothelial cell culture medium containing M199 (GIBCO/BRL, Gaithersburg, MD), 10% heatinactivated FBS (Hyclone, Logan, UT), 100 µg/ml L-glutamine, 50 µg/ml heparin, 30 µg/ml endothelial cell growth supplement (Sigma, St. Louis, MO), 100 U/ml penicillin and 100 µg/ml streptomycin.
Vessels were incised longitudinally and oriented in such a fashion that the lumen side contacted the dish surface during in vitro culture. Well developed endothelial cell colonies were evident by day 14 and confluent monolayers were achieved by day 30 of culture. Colonies were fed weekly with complete medium and several passages of the primary cells were banked.
CD34 + cells plus HUBEC co-culture
Purified human ABM CD34 + cells were obtained from Poietics Technologies, Inc.
(Gaithersburg, MD). HUBEC were subcultured at 1 x 10 5 cells/well in gelatin-coated 6-well plates (Costar, Cambridge, MA) as previously described. 22 After 72 hours, HUBEC monolayers were washed with PBS and the spent medium was replaced with ex vivo expansion culture medium (5 mL/well) consisting of IMDM (GIBCO/BRL) containing 10% FBS, 200 µM L-glutamine, 2ng/mL GM-CSF, 5ng/mL IL-3, 5 ng/mL For personal use only. on April 15, 2017. by guest www.bloodjournal.org From IL-6, 120 ng/mL SCF, and 50 ng/mL flt-3 ligand (R & D Systems, Minneapolis, MN) to each well. Purified ABM CD34 + cells (1 x 10 5 ) were added to each well and cultures were maintained at 37 o C in 5% CO 2 atmosphere. After 7 days of culture, nonadherent cells were harvested by washing the monolayers gently with warm complete culture medium. In the HUBEC non-contact cultures, ABM CD34 + cells were plated in the upper compartment of the culture well, separated from HUBEC monolayers by transwell inserts (0.4 µm; Costar).
Immunofluorescence staining and cell cycle analysis
ABM CD34 + cells and cultured cells were stained with monoclonal antibodies against CD34-FITC and CD38-PE (Becton Dickinson-BD, San Jose, CA) and analyzed by FACS (Coulter Epics Elite, FL). Controls consisted of isotype-matched mAbs. We performed the surface, intracellular, DNA (SID) cell cycle analysis as previously described 29 using anti-CD34-APC (BD), CD38-PE (BD), Ki-67-FITC (Immunotech, ME), and 7-AAD (Sigma, MO). Isotype controls were performed in parallel for each sample.
In vitro methylcellulose colony forming assays
Purified ABM CD34 + cells and ex vivo cultured cells (5-500 x 10 2 ) were cultured in 35-mm culture dishes (Miles Laboratories, Naperville, IL) as previously described. 22 Culture media consisted of 1 mL of IMDM, 1% methylcellulose, 30% FBS, 10 U/mL erythropoietin, 2 ng/mL GM-CSF, 10 ng/mL IL-3, and 120 ng/mL SCF. At day 14, we evaluated triplicate cultures to determine the number of colonies (>50 cells) per dish.
For personal use only. on April 15, 2017. by guest www.bloodjournal.org From NOD/SCID marrow cells were washed x 2 and placed (1 x 10 5 ) in methylcellulose containing culture media containing the above noted human cytokines and analyzed at day 14 for evidence of human colonies.
Transplantation of fresh ABM CD34 + cells and HUBEC-cultured cells in
NOD/SCID mice NOD/SCID mice 30 were transplanted with either fresh purified ABM CD34 + cells or the progeny of ABM CD34 + cells cultured with HUBEC supplemented with GM-CSF + IL-3 + IL-6 + SCF + flt-3 ligand over a range of doses designed to achieve no engraftment in a significant fraction. To avoid donor variability, HUBEC cultures were established with the identical ABM CD34 + cells as used for transplantation into mice designated as the "fresh ABM CD34 + " group. Cells were transplanted via tail vein injection after irradiating the mice with 300 cGy using a 137 Cs source as previously described. 31 The mice received no CD34accessory cells or exogenous cytokines to facilitate engraftment. Mice were sacrificed at week 8 and marrow samples were obtained by flushing their femurs and tibias with IMDM at 4 o C.
Flow cytometric analysis was performed as previously described using commercially available monoclonal antibodies against human leukocyte differentiation antigens to identify engrafted human leukocytes and discriminate their hematopoietic lineages. 31 Immunofluoresence staining of marrow cells was performed following our previously published procedures. 31 For personal use only. on April 15, 2017. by guest www.bloodjournal.org From
Statistical analysis
For purposes of our limiting dilution assays, we scored a transplanted mouse as positive if > 1% of the marrow cells expressed human-CD45 via FACS analysis, based upon the engraftment criteria established by Ueda et al. 27 We calculated the SRC frequency in each cell source using the maximum likelihood estimator as described previously by Taswell et al. for the single hit Poisson model. 12,27,32 2 provides a measure of the legitimacy of using pooled data and of the validity of applying the single hit model. 12, 30 We calculated confidence intervals for the frequencies using the profile likelihood method. As a confirmation of the maximum likelihood estimator, we also applied a minimum 2 estimator to the pooled data.
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Results
HUBEC co-culture supports ABM progenitor cell proliferation and expansion
HUBEC displayed cobblestone morphology at confluence and >90% expressed von Willebrand Factor, but we did not detect CD34 or CD38 expression by flow cytometry (data not shown). The effects of HUBEC contact and non-contact co-culture, liquid suspension culture, and human non-brain endothelial cell culture on CD34 + cell expansion and CFC generation were compared. All cultures were supplemented with GM-CSF + IL-3 + IL-6 + SCF + flt-3 ligand because our previous studies indicated that this combination optimized the expansion of ABM CD34 + cells. 21,22 HUBEC culture supported a 16.1-fold increase in total cells, a 5.4-fold increase in CD34 + cells, and a 212-fold increase in the CD34 + CD38subset (n=8) ( Table 1 ). CD34 + CD38cells increased from 1.6% of the total population at day 0 to 21.6% at day 7 and constituted 64% of the day 7 CD34 + cell pool. HUBEC non-contact cultures supported a 16.4-fold expansion of total cells, a 2.8-fold increase in CD34 + cells, and a 35-fold increase in the CD34 + CD38population.
In contrast, liquid suspension cultures and non-brain endothelial cell cultures supported similar increases in total cells and CD34 + cells, but neither maintained CD34 + CD38cells at day 7 ( Figure 1A -E) ( Table 1 ).
HUBEC co-culture supported a 15.1-fold increase in CFU-GM, a 5.2-fold increase in CFU-Mix, and an 8.0-fold increase in BFU-E compared to input values and this CFC activity was significantly greater than that produced by liquid suspension cultures and non-brain endothelial cell cultures (Table 1) . Non-contact HUBEC cultures supported an expansion of total CFC which was greater than either liquid suspension or non-brain endothelial cell culture, but optimal CFC production occurred in the HUBEC contact cultures. 
HUBEC-cultured cells engraft NOD/SCID mice at a higher frequency than fresh ABM CD34 + cells
NOD/SCID mice were transplanted with either fresh ABM CD34 + cells (n = 47) or the progeny of ABM CD34 + cells cultured with HUBEC x 7 days (n = 47) over a range of doses which resulted in non-engraftment in a fraction of the mice.
For personal use only. on April 15, 2017. by guest www.bloodjournal.org From Transplantation of 1 x 10 5 fresh ABM CD34 + cells resulted in no engraftment in 10 mice, whereas transplantation of 5 x 10 5 to 1 x 10 6 ABM CD34 + cells resulted in engraftment in only 10 of 22 recipients (45%) at low huCD45 + cell levels (mean 3.3%) ( Figure 3A-C) . At a dose of 1.5 x 10 6 ABM CD34 + cells, 7 of 7 transplanted mice showed human cell engraftment, suggesting that non-limiting numbers of SRC were present at that dose ( Figure 3D ). When the progeny of HUBEC cultures over the same dose range were transplanted, the rate of NOD/SCID engraftment increased ( Fig. 3A -C).
The progeny of 1 x 10 5 ABM CD34 + cells cultured with HUBEC engrafted in 2 of 10 mice and the progeny of 5 x 10 5 to 1 x 10 6 ABM CD34 + cells engrafted in 21 of 22 mice (96%) at high levels (mean 11.7% huCD45 + cells) ( Fig. 3A-C) . Twelve mice transplanted with 5 x 10 5 to 1 x 10 6 fresh ABM CD34 + cells showed no human cell engraftment, but all 12 mice transplanted with the HUBEC-cultured progeny of these ABM CD34 + cells demonstrated engraftment of > 1% huCD45 + cells. At a dose of 1.5
x 10 6 ABM CD34 + cells, HUBEC-cultured progeny engrafted in 7 of 7 mice at levels of huCD45 + cell engraftment equivalent to fresh ABM CD34 + cells (Fig. 3D ).
In order to assess the capacity of non-contact HUBEC cultures to maintain SRC, we also transplanted NOD/SCID mice with the progeny of ABM CD34 + cells cultured in this manner. The progeny of 1.5 x 10 6 ABM CD34 + cells plated in HUBEC noncontact cultures engrafted in 7 of 7 mice at a high levels (mean 62.8% huCD45 + ) comparable to the engraftment observed with the progeny of contact HUBEC-cultured cells transplanted at the same dose ( Figure 3E ). As a control, we also transplanted mice For personal use only. on April 15, 2017. by guest www.bloodjournal.org From with the progeny of ABM CD34 + cells which were plated in liquid suspension cultures supplemented with the identical cytokines for 7 days. None of the 3 mice in this group showed human cell engraftment or human CFC activity ( Figure 3E ). Figure 4A shows human CD45 + cell engraftment within a representative mouse transplanted with fresh ABM CD34 + cells (1 x 10 6 ) versus an animal transplanted with the progeny of the same dose of ABM CD34 + cells following HUBEC culture.
HUBEC-cultured cells engraft in NOD/SCID mice with multilineage differentiation
Detailed FACS analysis demonstrated lymphoid and myeloid differentiation in mice transplanted with limiting doses of HUBEC-cultured cells ( Figure 4B ). The proportion of CD34 + cells, CD19 + B cells, and CD13 + myeloid cells was highly similar within mice transplanted with limiting doses of HUBEC-cultured cells as compared to mice engrafted using fresh ABM CD34 + cells, indicating that a highly primitive repopulating cell was sustained during HUBEC culture ( Table 2 ). Detection of human CFC within NOD/SCID mice correlated closely with the hu-CD45 + cell engraftment which we observed. Mice transplanted with the progeny of 1 x 10 6 ABM CD34 + cells cultured with HUBEC demonstrated multilineage human CFC activity which was 41-fold greater than the human CFC activity within mice transplanted with the same dose of fresh ABM CD34 + cells ( Table 2) .
HUBEC co-culture increases the frequency of SRC within human bone marrow
For statistical analysis, we pooled data from the limiting dilution assays of fresh ABM CD34 + cells and HUBEC-cultured cells, according to methods previously described. 12, 27 We calculated the frequency of SRC using the maximum likelihood estimator. 32 The value of 2 in all cases was not statistically significant (P > 0.10), demonstrating internal consistency in our assays and allowing pooling of the data. The frequency of SRC within fresh ABM CD34 + cells was 1 in 9.9 x 10 5 cells (95% Confidence interval [CI]: 1/650,000 -1/1,600,000) ( Figure 5A ). The SRC frequency within HUBEC-cultured cells was significantly higher at 1 in 240,000 cells (CI: 1/140,000 -1/410,000) ( Figure 5B ). Therefore, co-culture of adult human ABM CD34 + cells with HUBEC monolayers supported a 4.1-fold increase in SRC. As further confirmation of the validity of applying the single-hit Poisson model to our limiting dilution assay, we also estimated the frequency of SRC using the minimum 2 estimation. 12 2 was again not significant in all cases (P > 0.20).
.
For personal use only. on April 15, 2017. by guest www.bloodjournal.org From Bone marrow transplantation is a curative therapy for an increasing number of malignant and non-malignant diseases. 33 However, the ex vivo expansion of adult bone marrow for application in gene therapy, immune tolerance induction, 34 and other diseases has been unsuccessful due to the differentiation and cell death which occurs when these cells are exposed to cytokines. [1] [2] [3] [4] [5] In this study, using a limiting dilution analysis, we have demonstrated for the first time that the SCID-repopulating cell numbers within adult ABM can be quantitatively increased via ex vivo co-culture with primary human brain endothelial cells (HUBEC). Co-culture of ABM CD34 + cells with HUBEC supplemented with GMCSF + IL-3 + IL-6 + SCF + flt-3 ligand induced >95% of the CD34 + CD38population to enter cell division and supported a 4.1-fold increase in SRC as compared to starting ABM CD34 + populations. Since stem cell division and maintenance of stem cell repopulating capacity are requirements for successful retroviral gene transfer, the HUBEC culture method may provide significant advantages for clinical gene therapy protocols. Although other factors, such as the expression of retroviral receptors on target stem cells, 35 are also important predictors of the success of retroviral gene therapy, our previous investigations have shown that co-cult ure of human ABM CD34 + cells with a porcine brain endothelial cell line (PMVEC) increased the gene transfer efficiency into the CD34 + CD38subset in the absence of measurable increases in the expression of retroviral receptors. 36 We are currently examining the 50, 51 In this study, non-contact HUBEC cultures maintained a percentage of CD34 + CD38cells at day 7 and, more importantly, the progeny of these cultures maintained SCID repopulating capacity. Although we did not perform a limiting dilution analysis to estimate the SRC frequency within non-contact HUBEC cultures, our results suggest a differential maintenance of SRC within non-contact HUBEC cultures as compared to liquid suspension cultures. The lack of requirement for cell-tocell contact may also be clinically advantageous since endothelial cell contamination of hematopoietic grafts would be eliminated.
Since the clinical transplantation of cord blood CD34 + cells is limited by low
cell numbers and delayed neutrophil/platelet engraftment, 52 we are currently testing the capacity of HUBEC culture to expand repopulating cells within this population.
Additionally, we will be performing serial transplantation studies to confirm that HUBEC co-culture maintains cells with long-term repopulating capacity 53,54 and we plan to test HUBEC culture with other cytokine combinations, such as SCF + flt-3 ligand + TPO + IL-6/sIL-6R, 27 in order to further augment the expansion of SRC presented here. Finally, the concentrations of IL-3 (5 ng/mL), IL-6 (5 ng/mL), and GMCSF (2 ng/mL) which we utilized in this study were lower than other investigators have previously applied to induce stem cell proliferation in vitro. 55, 56 We will additionally test whether higher concentrations of these cytokines might further increase the SRC expansion observed here.
For personal use only. on April 15, 2017. by guest www.bloodjournal.org From of human cord blood SRC, this progress has not translated into successful methods for the ex vivo expansion of either bone marrow or peripheral blood mobilized stem cells.
The limiting dilution analysis presented here demonstrates that long term repopulating cells within adult human bone marrow can be increased via exposure to human brain endothelial cells. This culture method may prove clinically useful for both the ex vivo expansion and genetic modification of adult human bone marrow stem cells. Purified human ABM CD34 + cells (5 x 10 5 ) were plated per culture treatment (n=8) as described in the Materials and Methods. Non-adherent cells were harvested on day 7 of culture and analyzed via flow cytometry. Numbers in parentheses in the Cell yield and CD34 + columns reflect the fold increase in these populations following culture. Numbers in parentheses in the CD34 + CD38 + and CD34 + CD38columns indicate the percentage of each population as a subset of the total population. CFC values represent the total number of CFC per culture. For personal use only. on April 15, 2017. by guest www.bloodjournal.org From
